Efficacy of Gao Mo therapy in treatment of aromatase inhibitor-related osteoarticular symptoms in breast cancer patients
10.39698j.issn.1671-8283.2025.04.006
- VernacularTitle:膏摩疗法对乳腺癌患者芳香化酶抑制剂相关骨关节症状的影响
- Author:
Yuanmei HE
1
;
Kun CHEN
1
;
Liling ZHANG
1
;
Xiaoqing WU
1
;
Fen WU
1
Author Information
1. 广东省第二中医院乳腺科,广东 广州,510095
- Publication Type:Journal Article
- Keywords:
Gao Mo therapy;
breast cancer;
aromatase inhibitor-related osteoarticular symptoms;
pain;
quality of life;
radomized controlled trial
- From:
Modern Clinical Nursing
2025;24(4):38-44
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyse the efficacy of Gao Mo therapy in the treatment of aromatase inhibitor-related osteoarticular symptoms in breast cancer patients.Methods A total of 80 breast cancer patients with aromatase inhibitor-related osteoarticular symptoms were selected from the breast clinic of a Tier-IIIA hospital in Guangdong Province between January and August 2024.The patients were divided into an intervention group and a control group according to the random number table,with 40 patients per group.Patients in the control group received routine nursing care,while the patients in the intervention group received Gao Mo therapy for 4 weeks based on the intervention of the control group.The two groups were compared with in terms of pain level,index of knee osteoarthritis,and quality of life of the patients with breast cancer before intervention and at 1st,2nd and 4th weeks after intervention.Results Before the intervention,the two groups presented no significant differences in scores of pain assessment,knee osteoarthritis index and quality of life(P>0.05).Analysis of variance for repeated measures showed that the main effects of time and group as well as the interaction effect,were statistically significant in scores of pain assessments in both groups(both P<0.05).The main effects of time and the interaction effect were statistically significant in scores of knee osteoarthritis index and quality of life assessments at different time points(both P<0.05),but there was no statistically significant difference in the main effect between groups(both P>0.05).After 4 weeks of intervention,the intervention group demonstrated significantly lower scores in knee function and pain assessments with a significantly higher scores in the total quality of life assessment in comparison with those of the control group(all P<0.05).Conclusion Gao Mo therapy can mitigate the aromatase inhibitor-related osteoarticular symptoms in breast cancer patients,enhance the function of knees,and improve the quality of life of the patients with breast cancer.
